 |
answer text |
<p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting
strategically important products that will have the biggest impact on patient health
outcomes and/or the delivery of NHS services. This may include those which help control
hospital-acquired infections.</p><p>The AAC has already had made significant progress
towards getting the best innovations to patients quicker and at a better cost for
the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath
and Plus Sutures, products designed to reduce infection rates, on the Innovation and
Technology Payment programme. SecurAcath is a device to secure catheters that reduces
the infection risk for patients with a peripherally inserted central catheter and
has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site
infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts
to be supported this year.</p><p> </p>
|
 |
